Literature DB >> 27337955

The effects of p21 gene C98A polymorphism on development of uterine leiomyoma in southeast Iranian women.

Saeedeh Salimi1,2, Azam Hajizadeh2, Minoo Yaghmaei3, Sodabeh Rezaie4, Mahnaz Shahrakypour5,6, Batool Teimoori4, Mahboube Parache4, Anoosh Naghavi1, Mojgan Mokhtari4.   

Abstract

Uterine leiomyoma (UL) is a monoclonal tumor which arises from uninhibited proliferation of a single myometrial cell; therefore, the imbalance in cell cycle regulation could be a key event in its development. In the present study, we aimed to assess the association of p21 gene polymorphisms and UL. Genomic DNA was extracted from blood samples of 154 women with UL and 197 age-, BMI-, and ethnically matched controls. p21 C98A (rs1801270) and C70T (rs1059234) polymorphism genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. The CA genotype of p21 C98A polymorphism was significantly higher in UL women (28 %) compared to the controls (18 %), and the UL risk was 1.8-fold greater in women with CA genotype compared to CC genotype before and after adjusting for age, BMI, and ethnicity (OR, 1.8 [95 % CI, 1.1 to 3]; P = 0.02). There was no association between the AA genotype of p21 C98A polymorphism and UL. Moreover, the frequency of p21 98A allele was significantly higher in the UL women compared to controls (17 vs. 12 %, p = 0.04). The p21 C70T polymorphism did not correlate with UL before and after adjusting for age, BMI, and ethnicity. There was no difference in haplotype frequency of p21 C70T and C98A polymorphisms between UL patients and the controls. CA genotype of p21 C98A polymorphism may be a risk factor for UL susceptibility; however, p21 C70T polymorphism did not associate with UL.

Entities:  

Keywords:  Gene; Polymorphism; Uterine leiomyoma; p21

Mesh:

Substances:

Year:  2016        PMID: 27337955     DOI: 10.1007/s13277-016-5078-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  36 in total

1.  p53-induced p21 controls DNA replication.

Authors:  S Waga; R Li; B Stillman
Journal:  Leukemia       Date:  1997-04       Impact factor: 11.528

2.  Immunohistochemical localization of p21(WAF1/CIP1) in normal, hyperplastic, and neoplastic uterine tissues.

Authors:  J P Palazzo; W E Mercer; A J Kovatich; M McHugh
Journal:  Hum Pathol       Date:  1997-01       Impact factor: 3.466

3.  P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.

Authors:  Ju-Won Roh; Bu Kyung Kim; Chae Hyeong Lee; Jongseung Kim; Hyun Hoon Chung; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Sang-Yoon Park; Soon-Beom Kang
Journal:  Oncol Res       Date:  2010       Impact factor: 5.574

Review 4.  The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

Authors:  Andrei L Gartel; Angela L Tyner
Journal:  Mol Cancer Ther       Date:  2002-06       Impact factor: 6.261

Review 5.  Quantitative Assessment the Relationship between p21 rs1059234 Polymorphism and Cancer Risk.

Authors:  Yong-Sheng Huang; Qian-Qian Fan; Chuang Li; Meng Nie; Hong-Yang Quan; Lin Wang
Journal:  Asian Pac J Cancer Prev       Date:  2015

6.  Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.

Authors:  Kaori Kumazaki; Masahiro Nakayama; Noriyuki Suehara; Yoshinao Wada
Journal:  Hum Pathol       Date:  2002-11       Impact factor: 3.466

7.  Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.

Authors:  H Fan; C Villegas; A Huang; J A Wright
Journal:  Cancer Res       Date:  1996-10-01       Impact factor: 12.701

8.  WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.

Authors:  W S el-Deiry; J W Harper; P M O'Connor; V E Velculescu; C E Canman; J Jackman; J A Pietenpol; M Burrell; D E Hill; Y Wang
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

9.  Association of cyclin D1 G870A polymorphism with uterine leiomyoma in women whose body mass index values are above 25 kg/m2.

Authors:  S S Han; J H No; Y T Jeon; J W Kim; N H Park; Y S Song; S B Kang; H P Lee
Journal:  Hum Reprod       Date:  2008-01-07       Impact factor: 6.918

10.  MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk.

Authors:  Stian Knappskog; Per E Lønning
Journal:  Oncotarget       Date:  2011-03
View more
  3 in total

1.  Analysis of polymorphisms, promoter methylation, and mRNA expression profile of maternal and placental P53 and P21 genes in preeclamptic and normotensive pregnant women.

Authors:  Mahdiyeh Harati-Sadegh; Leila Kohan; Batool Teimoori; Mehrnaz Mehrabani; Saeedeh Salimi
Journal:  J Biomed Sci       Date:  2019-11-08       Impact factor: 8.410

2.  Association of ACE I/D and AGTR1 A1166C Gene Polymorphisms and Risk of Uterine Leiomyoma: A Case-Control Study.

Authors:  Farshid Keshavarzi; Batool Teimoori; Farahnaz Farzaneh; Mojgan Mokhtari; Darya Najafi; Saeedeh Salimi
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

3.  Association between tobacco substance usage and a missense mutation in the tumor suppressor gene P53 in the Saudi Arabian population.

Authors:  Mikhlid H Almutairi; Bader O Almutairi; Turki M Alrubie; Sultan N Alharbi; Narasimha R Parine; Abdulwahed F Alrefaei; Ibrahim Aldeailej; Abdullah Alamri; Abdelhabib Semlali
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.